Prospect News: News for Arch Therapeutics Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, PP only > All stories on Arch Therapeutics Inc. > Stories on Arch Therapeutics Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Arch Therapeutics Inc.

6/2/2016	PP	Arch Therapeutics concludes $3.39 million private placement of units
5/27/2016	PP	Arch Therapeutics negotiates $3.4 million brokered placement of units
7/6/2015	PP	Arch Therapeutics completes $3.17 million private placement of units
6/1/2015	PP	Arch Therapeutics amends series C warrants sold to Cranshire Capital
3/13/2015	PP	Arch Therapeutics wraps $750,000 private placement of 8% convertibles
2/10/2014	PP	Arch Therapeutics settles $2.85 million private placement of its units
10/4/2013	PP	Arch Therapeutics pockets $1 million through placement of 10% notes
6/26/2013	PP	Arch seals $1.25 million of $2 million private placement of its units

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.